Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?
作者信息
Georgianos Panagiotis I, Balaskas Elias V, Zebekakis Pantelis E
机构信息
Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
出版信息
J Clin Hypertens (Greenwich). 2016 Oct;18(10):1076. doi: 10.1111/jch.12836. Epub 2016 May 11.
Abstract
摘要
相似文献
1
Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?治疗晚期慢性肾脏病糖尿病患者的高血压：我们应牢记什么？
J Clin Hypertens (Greenwich). 2016 Oct;18(10):1076. doi: 10.1111/jch.12836. Epub 2016 May 11.
2
Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?治疗患有晚期慢性肾脏病的糖尿病患者的高血压：我们应该注意什么？
J Clin Hypertens (Greenwich). 2016 Oct;18(10):1077-1078. doi: 10.1111/jch.12839. Epub 2016 May 11.
3
Managing chronic kidney disease in diabetes patients with the latest chemical therapies.管理糖尿病患者的慢性肾病：最新的化学疗法。
Expert Rev Clin Pharmacol. 2019 Jan;12(1):53-60. doi: 10.1080/17512433.2019.1552829. Epub 2018 Dec 3.
4
Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.糖尿病作为慢性肾脏病的病因或合并症及其预后：Gonryo研究
Clin Exp Nephrol. 2018 Apr;22(2):328-336. doi: 10.1007/s10157-017-1451-4. Epub 2017 Jul 27.
5
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.巴多昔芬甲基用于2型糖尿病和晚期慢性肾病
N Engl J Med. 2014 May 1;370(18):1768-9. doi: 10.1056/NEJMc1400872.
6
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.巴多昔芬甲基用于2型糖尿病和晚期慢性肾病
N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872.
7
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.巴多昔芬甲酯用于2型糖尿病和晚期慢性肾病的研究
N Engl J Med. 2014 May 1;370(18):1767-8. doi: 10.1056/NEJMc1400872.
8
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.巴多昔芬甲基酯用于2型糖尿病和晚期慢性肾病的研究
N Engl J Med. 2014 May 1;370(18):1767. doi: 10.1056/NEJMc1400872.
9
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.巴多昔芬甲基用于2型糖尿病和晚期慢性肾病
N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872.
10
Prognostic evaluation model of diabetic nephropathy patients.糖尿病肾病患者的预后评估模型
Ann Palliat Med. 2021 Jun;10(6):6867-6872. doi: 10.21037/apm-21-1454.
本文引用的文献
1
Renal Function Alters Antihypertensive Regimens in Type 2 Diabetic Patients.肾功能改变2型糖尿病患者的降压方案。
J Clin Hypertens (Greenwich). 2016 Sep;18(9):878-83. doi: 10.1111/jch.12776. Epub 2016 Mar 2.
2
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.在血压得到控制、未得到控制的难治性和非难治性高血压患者中，肾脏、心血管及死亡结局的比较风险
Kidney Int. 2015 Sep;88(3):622-32. doi: 10.1038/ki.2015.142. Epub 2015 May 6.
3
Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.慢性肾脏病与普通高血压人群中难治性高血压的比较流行病学
Semin Nephrol. 2014;34(5):483-91. doi: 10.1016/j.semnephrol.2014.08.001.
4
Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds.临床实践中的利尿剂。第一部分：利尿剂化合物的作用机制、药理作用和临床适应证。
Expert Opin Drug Saf. 2010 Mar;9(2):243-57. doi: 10.1517/14740330903499240.
5
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.难治性高血压：诊断、评估与治疗。美国心脏协会高血压研究理事会专业教育委员会的科学声明。
Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.
6
K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.《肾脏病预后质量倡议（K/DOQI）慢性肾脏病高血压及抗高血压药物临床实践指南》
Am J Kidney Dis. 2004 May;43(5 Suppl 1):S1-290.
Zotero 插件